4//SEC Filing
PAUL LAURENCE E 4
Accession 0000885590-12-000029
CIK 0000885590other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:57 PM ET
Size
9.8 KB
Accession
0000885590-12-000029
Insider Transaction Report
Form 4
PAUL LAURENCE E
Director
Transactions
- Purchase
Common Stock, no par value
2012-05-14$51.03/sh+2,100$107,156→ 34,497 total - Purchase
Common Stock, no par value
2012-05-14$51.03/sh+2,900$147,987→ 37,397 total
Footnotes (1)
- [F1]This number represents common shares purchased by the officer, as well as other outstanding equity awards that were previously reported in Table 1.
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001190966
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 5:57 PM ET
- Size
- 9.8 KB